Advanced therapy medicinal products

Mechanism

Related News

Virus Filters Markets Poised for Strong Growth Through 2035 on Biologics Demand

Jun 06, 2026

Global virus filters markets are projected for strong growth through 2035, with CAGRs of 7.2% to 8.2%, driven by expanding biologics production and stringent regulatory mandates for viral safety. Monoclonal antibody manufacturing remains the largest segment, while advanced therapy medicinal products are the fastest-growing area of demand.

TIL therapy shows durable responses in refractory melanoma as adoption expands

May 13, 2026

Tumour-infiltrating lymphocyte therapy has shown durable responses in refractory melanoma, including a 31.4% objective response rate in phase II data. The 2024 FDA approval of Lifileucel marked a milestone as regulators in other markets continue reviews.

Gene Therapy for Knee Osteoarthritis Advances; India Plans Regulatory Framework

Mar 09, 2026

Five intra-articular gene therapy platforms for knee osteoarthritis are in human trials in the US, while India prepares regulatory guidelines for mRNA, gene and cell therapies to accelerate innovation.